Octagon Capital Advisors LP - Dec 31, 2024 Form SCHEDULE 13G Schedule Report for Taysha Gene Therapies, Inc. (TSHA)

Filing Manager
Octagon Capital Advisors LP
Reporting Manager
Octagon Capital Advisors LP
Security
Taysha Gene Therapies, Inc. Common Stock, $0.00001 par value
Symbol
TSHA
Shares outstanding
205M shares
Disclosed Ownership
10.5M shares
Ownership
5.1%
Form type
SCHEDULE 13G
Date filed
2/5/2025, 06:05 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Octagon Capital Advisors LP 5.1% 10.5M 0 10.5M /s/ Ting Jia Managing Member
Octagon Investments Master Fund 5.1% 10.5M 0 10.5M /s/ Ting Jia Managing Member, Octagon Investments GP, LLC, its general partner
Ting Jia 5.1% 10.5M 0 10.5M /s/ Ting Jia Ting Jia